
China NMPA approves Bracco Imaging’s contrast agent for infertility diagnosis
The diagnostic performance of HyCoSy with SF6 microbubbles claims to have been validated by a meta-analysis of 24 trials.

The diagnostic performance of HyCoSy with SF6 microbubbles claims to have been validated by a meta-analysis of 24 trials.

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as cardiomyocytes—and the heart’s limited regenerative capacity often lead to chronic heart failure. Current treatment strategies manage symptoms but do not repair the underlying damage.

In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune system’s most powerful cancer-killing agents.

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard.

A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key driver in T-cell development and function.

MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.

EvoEndo announced today that it received expanded FDA clearance for its Model LE gastroscope, covering patients of all ages.

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke.

Current methods for cancer diagnosis are based on identifying biomarkers—molecules that reveal a particular state or process in the body—produced by the tumor or associated proteins. Not surprisingly, these markers are more abundant once the tumor has already developed significantly. And the more advanced the tumor, the more difficult it is to find effective treatment options.

Scientists at UCSF have found that endometriosis—a painful chronic disease affecting 10% of women that often goes undiagnosed—often occurs alongside conditions like cancer, Crohn’s disease, and migraine.